Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Velázquez

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry|June 24, 2004
Synthesis and biological evaluation of 1,4-dihydropyridine calcium channel modulators having a diazen-1-ium-1,2-diolate nitric oxide donor moiety for the potential treatment of congestive heart failureCarlos Velázquez, Edward E Knaus
Journal of Medicinal Chemistry|June 10, 2005
Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studiesCarlos Velázquez, P N Praveen Rao, Edward E Knaus
Bioorganic & Medicinal Chemistry|May 25, 2005
Design and synthesis of alkyl 7,7-dihalo-3-methyl-5-(nitrophenyl)-2-azabicyclo[4.1.0]hept-3-ene-4-carboxylates with calcium channel antagonist activityJavid S Mojarrad, Dean Vo, Carlos Velázquez, et al.
Asian Cardiovascular & Thoracic Annals|January 4, 2013
Primary inferior vena cava leiomyosarcoma: reconstruction is not mandatoryEmiliano A Rodríguez-Caulo, Carlos Velázquez, Bella Ramírez, et al.
Bioorganic & Medicinal Chemistry|March 23, 2005
Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agentsCarlos Velázquez, P N Praveen Rao, Robert McDonald, et al.
Cirugia Espanola|December 11, 2012
[Fusiform giant splenic artery aneurysm]Emiliano A Rodríguez-Caulo, Omar Araji, Nuria Miranda, et al.
Journal of the Experimental Analysis of Behavior|February 20, 2019
Bayesian methods applied to the generalized matching lawManuel Villarreal, Carlos Velázquez, José L Baroja, et al.
Steroids|February 19, 2020
Cucurbitacin IIb, a steroidal triterpene from Ibervillea sonorae induces antiproliferative and apoptotic effects on cervical and lung cancer cellsHeriberto Torres-Moreno, Maria Carla Marcotullio, Carlos Velázquez, et al.
Bioorganic & Medicinal Chemistry|October 22, 2008
Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studiesKhaled R A Abdellatif, Morshed Alam Chowdhury, Ying Dong, et al.
Organic & Biomolecular Chemistry|July 29, 2010
Acyclic triaryl olefins possessing a sulfohydroxamic acid pharmacophore: synthesis, nitric oxide/nitroxyl release, cyclooxygenase inhibition, and anti-inflammatory studiesZhangjian Huang, Carlos Velázquez, Khaled Abdellatif, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry|June 24, 2004
Synthesis and biological evaluation of 1,4-dihydropyridine calcium channel modulators having a diazen-1-ium-1,2-diolate nitric oxide donor moiety for the potential treatment of congestive heart failureCarlos Velázquez, Edward E Knaus
Journal of Medicinal Chemistry|June 10, 2005
Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studiesCarlos Velázquez, P N Praveen Rao, Edward E Knaus
Bioorganic & Medicinal Chemistry|May 25, 2005
Design and synthesis of alkyl 7,7-dihalo-3-methyl-5-(nitrophenyl)-2-azabicyclo[4.1.0]hept-3-ene-4-carboxylates with calcium channel antagonist activityJavid S Mojarrad, Dean Vo, Carlos Velázquez, et al.
Asian Cardiovascular & Thoracic Annals|January 4, 2013
Primary inferior vena cava leiomyosarcoma: reconstruction is not mandatoryEmiliano A Rodríguez-Caulo, Carlos Velázquez, Bella Ramírez, et al.
Bioorganic & Medicinal Chemistry|March 23, 2005
Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agentsCarlos Velázquez, P N Praveen Rao, Robert McDonald, et al.
Cirugia Espanola|December 11, 2012
[Fusiform giant splenic artery aneurysm]Emiliano A Rodríguez-Caulo, Omar Araji, Nuria Miranda, et al.
Journal of the Experimental Analysis of Behavior|February 20, 2019
Bayesian methods applied to the generalized matching lawManuel Villarreal, Carlos Velázquez, José L Baroja, et al.
Steroids|February 19, 2020
Cucurbitacin IIb, a steroidal triterpene from Ibervillea sonorae induces antiproliferative and apoptotic effects on cervical and lung cancer cellsHeriberto Torres-Moreno, Maria Carla Marcotullio, Carlos Velázquez, et al.
Bioorganic & Medicinal Chemistry|October 22, 2008
Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studiesKhaled R A Abdellatif, Morshed Alam Chowdhury, Ying Dong, et al.
Organic & Biomolecular Chemistry|July 29, 2010
Acyclic triaryl olefins possessing a sulfohydroxamic acid pharmacophore: synthesis, nitric oxide/nitroxyl release, cyclooxygenase inhibition, and anti-inflammatory studiesZhangjian Huang, Carlos Velázquez, Khaled Abdellatif, et al.
Pageof 3